Formulation and evaluation of transdermal patch of vildagliptin
Abstract
Objective: In the present research, the transdermal patch of vildagliptin was fabricated by using sustained release hydrophilic and lipophilic polymers containing permeation enhancer and thoroughly evaluated.
Methods: The transdermal patches of vildagliptin were prepared using the combination of polymers in different concentration with permeation enhancer and plasticizer was used for the formulating transdermal drug delivery system. The thickness, folding endurance, tensile strength, percentage of moisture content, percentage of moisture uptake, drug content analysis, scanning electron morphology (SEM) was evaluated.
Results: All the formulation was studied and all data fitted on zero order and first order, to explain the diffusion mechanism and pattern. The % cumulative drug release was calculated over the study time range in 0-10 h. Data analysis for order of release kinetics the formulation followed zero order release kinetics. From the in-vitro permeation study it was confirmed that the release of formulation F3 was to be found higher as compared to other formulation.
Conclusion: The preparation of matrix type transdermal patch appears to be a most effective approach from the process development and scale-up point of view.
Downloads
References
2. Arabi H, Hashemi SA, Ajdari N. Preparation of a transdermal delivery system and effect of membrane type for scopolamine drug. Iranian Polymer J 2002; 11: 245-249.
3. Ghosh B, Iyer D, Nair AB, Sree HN. Prospects of iontophoresis in cardiovascular drug delivery. J Basic Clin Pharm. 2012; 4: 25-30.
4. Jain NK. Controlled and novel drug delivery. CBS publisher and distributors, 1997: 100.
5. Gowda DV, Rajesh N, Somashekhara CN, Siddaramaiah. Development and evaluation of aceclofenac loaded transdermal film. Int J Pharmtech Res 2010; 2: 2224-2233.
6. Patel RP, Patel G, Baria A. Formulation and evaluation of transdermal patch of aceclofenac. Int J Drug Deliv 2009; 1: 41-51.
7. Gaikwad AK. Transdermal drug delivery system: formulation aspects and evaluation. J Pharm Sci 2013; 1: 1-10.
8. Kulkarni R, Doddayya H, Marihal SC, Patil CC, Habbu PV. Comparative evaluation of polymeric films for
transdermal application. The Eastern Pharmacist. 2000; 93: 109-111.
9. Prabhakar P, Shah S, Gundad. Formulation development and investigation of domperidone transdermal patches. Int J Pharm Investig 2011; 1: 240-246.
10. Jadhav RT, Kasture PV, Gattani SG, Surana SJ. Formulation and evaluation of transdermal films of diclofenac sodium. Int J Pharmtech Res 2009; 1: 1507-1511.
11. Murthy SN, Rani S, Hiremath R. Formulation and evaluation of controlled release transdermal patches of theophylline-salbutamol sulphate. Ind J Pharm Edu Res 2001; 27: 1057-1062.
12. Saxena M, Mutalik S, Reddy MS. Formulation and evaluation of transdermal patches of metoclopramide hydrochloride. Indian drugs 2006; 43: 740-745.
13. Mali AD, Bathe R, Patil M. An updated review on transdermal drug delivery systems. Int J Advan Scient Res 2015; 1: 244-254.
14. Darwhekar G, Jain DK, Patidar PK. Formulation and evaluation of transdermal drug delivery system of Clopidogrel bisulfate. Asian J Pharm Life Sci 2011; 1: 26.
15. Prajapati ST, Patel CG, Patel CN. Formulation and Evaluation of transdermal Patch of repaglinide. ISRN Pharma 2001; 2: 65-78.
16. Arora P. Mukherjee B. Design development of physicochemical in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. Indian J Pharm Sci 2002; 91: 2076-2089.
17. Gupta R, Bajpal M, Bhattacharya A. Formulation and in vitro evaluation of transdermal drug delivery system of tizanidine hydrochloride, Indian J Pharm Sci 2008; 7: 208-213.
18. Patel KN, Patel HK, Patel VA. Formulation and characterization of drug in adhesive transdermal patches of diclofenac acid. Int J Pharm Pharm Sci, 2012; 4: 296–299.
Copyright © Author(s) retain the copyright of this article.

.